. 2019 Jul 9;20(13):3374. doi: 10.3390/ijms20133374

Table 2.

Resveratrol and glucose uptake.

Glucose Uptake	Glucose Analog Used	Cell Type	Reference
inhibit (in vivo)	2-deoxy-2-[18F]fludeoxyglucose ([¹⁸F]FDG) uptake	A2780, SKOV3 (injected in female nu/nu mice).	[166]
inhibit (in vivo)	2-deoxy-2-[¹⁸F]fludeoxyglucose ([¹⁸F]FDG) uptake	LLC (injected in BALB/c-n mice)	[151]
inhibit (in vitro)	3-O-methyl-D-glucose (OMG) or 2-deoxy glucose (2-DG) uptake	HL60, U937, RBC	[116]
inhibit (in vitro)	(2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino]-2-deoxyglucose) (2-NBDG) uptake	PA-1, OVCAR3, MDAH2774	[147]
inhibit (in vitro)	[³H]-2-DG uptake	A2780, MDAH-2774, HOC-1, HOC-8, OVCA 429, and OVCA 432 SKOV3	[117]
inhibit (in vitro)	Glucose Oxidase Assay Kit	A2780, SKOV3	[119]
Increase (in vitro)	2-deoxy-D-[³H] glucose uptake	3T3-L1	[120]
Inhibit (in vitro)	Glucose (hexokinase) assay kit	HUVEC	[149]
inhibit (in vitro)	(2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino]-2-deoxyglucose) (2-NBDG) uptake	Neuro-2a (N2A)	[121]
Increase (in vitro)	2-doxy-D-glucose (2DG)	L6	[167]
Increase (in vitro)	[³H] DG	BeWo	[168]
Increase (in vitro)	2-deoxy-D-glucose (2DG)	Placental lobules	[150]